(Corrects bullet point and paragraphs 1 and 5 to delete attribution of NBG share price to bank's results, which were issued after the market close)
* FTSEurofirst 300 index closed down 0.1 percent
* Greece's NBG falls before results, misses forecasts
* Miners slip tracking lower copper prices
By Joanne Frearson
LONDON, March 18 (Reuters) - European shares fell on Thursday, led lower by the banking sector, with Greece's largest lender National Bank (NBG) <NBGr.AT> slipping 6 percent before a post-market results statement.
The pan-European FTSEurofirst 300 <
> index of top shares closed down 0.1 percent at 1,069.69 points, after trading in a range of 1,067.06-1,073.73 points."Given the decent run we have seen over the last couple of weeks, markets have become a little exhausted," said Gerhard Schwarz, head of global equity strategy at UniCredit.
"The market is waiting for new significant factors. Over the next few days there might be more scrutinizing over the Greece situation."
Banks took the most points off the index with lingering concerns over Greece's economic situation adding to market worries. Greek bank shares fell following a media report that the country may turn to the IMF to deal with its debt crisis.
Greece's finance minister later dismissed the report and said all options for getting support were still open. [
]After the market close National Bank of Greece released annual results which showed a 40 percent fall in its net profit to 923 million euros ($1.3 billion). [
]HSBC <HSBA.L>, Banco Santander <SAN.MC>, Barclays <BARC.L>, BBVA <BBVA.MC> and UBS <UBSN.VX> fell 1.7 to 1.9 percent.
Miners were lower as copper <MCU3=LX> prices fell 0.9 percent on a firmer dollar.
Antofagasta <ANTO.L>, BHP Billiton <BLT.L>, Eurasian Natural Resources Corporation <ENRC.L>, Rio Tinto <RIO.L> and Xstrata <XTA.L> slipped 0.6 to 1.7 percent.
ROCHE GAINS
Drugmakers added the most points to the index. Roche <ROG.VX> rose 0.6 percent after it said it sees blockbuster sales for at least 7 experimental drugs. [
]GlaxoSmithKline <GSK.L> gained 3.9 percent after Novartis <NOVN.VX> handed back U.S. rights to a drug widely believed to be a generic version of the company's lung blockbuster Advair.
Novartis was up 0.7 percent.
The personal goods sector was in demand. Adidas <ADSG.DE> gained 3.3 percent after peer Nike <NKE.N>, the largest global sports gear maker, beat Wall Street expectations in its third quarter.
Luxury good makers were higher after demand for Swiss watches rose for a second straight month in February. [
]Swatch Group <UHR.VX> and Richemont <CFR.VX> were up 2.2 and 1.8 percent respectively.
Energy stocks were in demand. British gas producer BG Group <BG.L> rose 1.5 percent on market talk of Exxon Mobil's <XOM.N> interest in the company, traders said.
BG Group declined to comment on the talk. Exxon was not immediately available for comments.
Across Europe, the FTSE 100 <
> index was down 0.04 percent, Germany's DAX < > fell 0.2 percent and France's CAC 40 < > slipped 0.5 percent. (Editing by Sharon Lindores)